We're making headlines

We're on a mission to transform medical research, for good. And people are taking notice.

Press release: "Antidote Technologies’ Business Development Leader Dave Mauro Named to the 2021 PharmaVOICE 100"

Vator News: "Today's entrepreneur: Laurent Schockmel, CEO of Antidote"

Vator News: "Antidote raises $23M to match patients with clinical trials"

Press release: "Antidote Raises $23 Million to Scale Digital Patient Engagement Services"

Press Release: "Antidote Technologies Registers Over 40,000 COPD Patients for Clinical Trial Matching Services"

Press release: "Antidote Technologies Drives Patient Recruitment for Three Pivotal COVID-19 Clinical Trials"

Press release: "Antidote Technologies Spearheads Recruitment for a COVID Early Treatment Fund Clinical Trial Recently Featured on CBS Program 60 Minutes"

Press release: "Antidote Technologies named a top innovator in new book for pharma industry"

PharmaVOICE 100: "Laurent Schockmel, Creating Transformative Connections"

PharmaVOICE: "Bringing the Patient Voice into Clinical Trials"

Press Contact
media-kit-cta